Biggest News Aggregation in the World
📰 Phase News

Page 1489 - Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Phase. Real-time updates on events, politics, business and more.

Cameroon to sign a XAF88.8 bln credit agreement for the finalization of the East entrance to Douala reconstruction project

(Business in Cameroon) - The Cameroonian Head of State, Paul Biya, recently empowered Minister of Economy, Alamine Ousmane Mey to sign, on behalf of Cameroon, a XAF88.8 billion credit agreement with Standard Chartered Bank London and UK Export Finance (Ukef). According to the presidential decree published in that regard, the loan will fund phase 2 of the project aimed at reconstructing the East entrance to Douala. During the said phase, the roadway at the entrance of the Cameroonian economic ...
Central African Republic City Of United Kingdom Central African Paul Biya Alamine Ousmane Mey

DGAP-News: Immunic, Inc. Announces Positive Top-Line Data From Investigator-Sponsored Phase 2 Proof-of-Concept Clinical Trial of IMU-838 in Primary Sclerosing Cholangitis

DGAP-News: Immun ... DGAP-News: Immunic, Inc. Announces Positive Top-Line Data From Investigator-Sponsored Phase 2 Proof-of-Concept Clinical Trial of IMU-838 in Primary Sclerosing Cholangitis vom 18.02.2021, 12:30 Uhr Bild: pixabay.com DGAP-News: Immunic, Inc. / Key word(s): Study results Immunic, Inc. Announces Positive Top-Line Data From Investigator-Sponsored Phase 2 Proof-of-Concept Clinical Trial of IMU-838 in Primary Sclerosing Cholangitis 18.02.2021 / 12:30 The issuer is solel...
United States Paula Schwartz Edna Kaplan Keith Lindor Johne Eaton Daniel Vitt

AIM ImmunoTech Inc.: AIM ImmunoTech Announces Ethics Committee Approval to Commence Phase 1 Clinical Study of Ampligen as an Intranasal Therapy

(2) OCALA, Fla., Feb. 16, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has received approval from the required Ethics Committee in the Netherlands to commence its Phase 1 clinical study on the safety of AIMs drug Ampligen as an intranasal therapy, a critical step in the companys ongoing efforts to develop Ampligen as a potential prophylaxis or treatment for COVID-19 and other respiratory viral diseases. Earlier this year, the company announcedthat ...
United States Matthijs Moerland Thomask Equels Centre For Human Drug Research Immunotech Inc Crescendo Communications

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

DGAP-News: Immunic, Inc. Announces That Oral Treatment IMU-838 Shows Evidence of Clinical Activity in Moderate COVID-19 in Phase 2 CALVID-1 Trial

DGAP-News: Immunic, Inc. Announces That Oral Treatment IMU-838 Shows Evidence of Clinical Activity in Moderate COVID-19 in Phase 2 CALVID-1 Trial Table: IMU-838 Shows Acceleration of Time to Clinical Improvement High-risk patients and patients aged over 65 years experienced a more substantial treatment benefit from IMU-838 than in the general patient population: - The 75% probability [5] to reach clinical improvement (based on investigator assessment) was accelerated by 3.8 days in IMU-838 trea...
United States Paula Schwartz Edna Kaplan Jessica Breu Andreas Muehler Daniel Vitt

Indonesia remains its vaccination campaign on Wednesday

(MENAFN)On Wednesday, Indonesia started the second phase of its vaccination campaign. The government plans to vaccinate 16.9 million public sector workers and 21.5 million people aged over 60 by May. The new phase initiated with Vice President Ma’ruf Amin, took his first dose of the Chinese Sinovac jab in the capital Jakarta and traders being immunized at the Tanah Abang market, the busiest textile hub in Southeast Asia. The Health Ministry stated that people included in the public worker ...
Legal Disclaimer Campaign The 16 9 What Time Is It Free Fire Vs Pubg Look Like
Source: menafn.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science